Overview


According to FutureWise analysis the market for intravenous (iv) ibuprofen in 2023 is US$ 6.07 billion, and is expected to reach US$ 16.85 billion by 2031 at a CAGR of 13.62%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Intravenous (IV) Ibuprofen Market trends that shall affect the overall market growth. Furthermore, it includes detaiPain/Inflammatory information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Intravenous (IV) Ibuprofen Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Cumberland Pharmaceuticals Inc
  • Alveda Pharmaceuticals, Inc. (acquired by Teligent, Inc.)
  • CSL Limited
  • Sandor Medicaids Pvt Ltd
  • PT. Soho Industri Pharmasi
  • Germin MEDt
  • Grifols S.A
  • Harbin Gloria Pharmaceuticals Co., Ltd.
  • Al Nabeel International Ltd.
  • Laboratorios Valmorca, C.A

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Indication

  • Pain/Inflammatory
  • Fever

By Age Group

  • Pediatrics
  • Adults

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Intravenous (IV) Ibuprofen Market By Indication, By Age Group and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
  • 2.   Research Methodology
  • 3.   Executive Summary
  • 4.   Global Intravenous (IV) Ibuprofen Market Variables, Trends and Scope
  • 5.   Market Overview
  • 6.   Global Intravenous (IV) Ibuprofen Market Analysis Tools
  • 7.   Global Intravenous (IV) Ibuprofen Market, By Indication Historical Analysis and Forecast 2024-2032 (USD Million)
  • 8.   Global Intravenous (IV) Ibuprofen Market, By Age Group Historical Analysis and Forecast 2024-2032 (USD Million)
  • 9.   North America Intravenous (IV) Ibuprofen Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 10.   Latin America Intravenous (IV) Ibuprofen Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 11.   Europe Intravenous (IV) Ibuprofen Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 12.   Asia Pacific Intravenous (IV) Ibuprofen Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 13.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
  • 14.   Market Share Analysis and Competitive Landscape
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
  • 16.   Pre and Post COVID-19 Impact
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients